Product Information
HALOPERIDOL DEC 500 MG/5 ML VL is a generic product labeled by Meitheal Pharmaceuticals Inc., priced at $15.5981 per ML under NDC 71288050405. Its NADAC has been published 227 times since Jun 1, 2022.
FDA first approved this application on Jul 26, 2021. Its Orange Book therapeutic-equivalence code is AO.
Strength
100 mg/mL
Manufacturer
Meitheal Pharmaceuticals Inc.NDC
71288050405
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOL DECANOATEApproval Type
Generic (ANDA)
FDA Application
ANDA214507FDA Approved
7/26/2021
TE Code
AO
On Market Since
7/26/2021
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL DEC 500 MG/5 ML VL has been published 227 times since Jun 1, 2022, and over the history we have for it it has declined 28.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.5981 per ML |
|---|---|
| All-time high | $29.6091 (Aug 10, 2022) |
| All-time low | $12.9792 (Jul 22, 2026) |
| 52-week high | $15.5981 |
| 52-week low | $12.9792 |
| Median price | $21.1051 |
| Average price | $20.6446 |
| Largest weekly change | +25.7% (Dec 21, 2022) |
| Weeks tracked | 227 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Meitheal Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Haloperidol Decanoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL DEC 500 MG/5 ML VL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL DEC 500 MG/5 ML VL, manufactured by Meitheal Pharmaceuticals Inc., is $15.5981 per ML (NDC 71288050405), effective Sep 30, 2026.
How has the price of HALOPERIDOL DEC 500 MG/5 ML VL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL DEC 500 MG/5 ML VL has declined 28.1%. It has been tracked across 227 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL DEC 500 MG/5 ML VL?
Since Jun 1, 2022, the NADAC for HALOPERIDOL DEC 500 MG/5 ML VL has ranged from a low of $12.9792 (Jul 22, 2026) to a high of $29.6091 (Aug 10, 2022), with a median of $21.1051 per ML.
Are there cheaper alternatives to HALOPERIDOL DEC 500 MG/5 ML VL?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOPERIDOL DEC 100 MG/ML VIAL, is $7.5241 per ML — about 52% below HALOPERIDOL DEC 500 MG/5 ML VL.
Who manufactures HALOPERIDOL DEC 500 MG/5 ML VL?
HALOPERIDOL DEC 500 MG/5 ML VL (NDC 71288050405) is labeled by Meitheal Pharmaceuticals Inc., and CMS classifies it as a generic product.